peptide · Research use only
TB-500
$140.00
Thymosin beta-4 fragment research peptide.
Select size / vial volume
10 mg
$140.00
About
TB-500 is an investigational peptide discussed alongside recovery and mobility research. Not approved for consumer use.
Research peptide — not approved for human consumption
Mechanism
Thymosin beta-4 fragment (TB-500) is studied for actin regulation, cell migration, and tissue remodeling signaling in injury-recovery models.
TB-500 works by shifting the internal scaffolding of cells so they can physically migrate, then mobilizing repair cells from elsewhere in the body toward the site of damage.
Research context
The systemic recruiter for tissue repair.
Researched areas
- Musculoskeletal recovery
- Tissue remodeling
- Flexibility and movement context (anecdotal research communities)
Reported side effects (research)
- Fatigue
- Headache
- Injection site redness
Cautions
- Combined with BPC-157 in recovery stacks — monitor overlapping goals
- Anticoagulants
Contraindications
- Pregnancy
- Active cancer history without oncology guidance
Storage & handling
- Refrigerate lyophilized and reconstituted material
- Protect from light
Reconstitution notes (research context)
Common vials: 5–10 mg. Higher mg vials may use 2–3 mL BAC water for measurable draws.
Content extracted one-way from Knowledge Library Phase-1 operational intelligence and/or Blueprint structured profiles · reformd:kl_curated:peptide:tb-500. For laboratory research only. Not for human use. Not medical advice.